As NTRK fusions (especially classical fusions) were mostly narrowed to MLH1/PMS2 deficiency cases and DNA mismatch repair (MMR), IHC testing was regularly undergone by all CRC patients. This evidence concerns the gene MLH1 and colorectal carcinoma.